It then translocates into the nucleus, binding to the promoter elements of relevant target genes and ultimately participating in the expression of pro-tumor and anti-apoptotic genes such as BCL2, TWIST, thereby exerting tumor-promoting effects [97–99]. This evidence concerns the gene BCL2 and neoplasm.